University officials cited legal concerns as their reason for ending the program.
A university spokesperson told The Baltimore Sun university leaders asked pharmacy school officials to cancel the classes after consulting with the Maryland Attorney General’s Office about the medical marijuana laws relating to the courses the program planned to offer.
Maryland physicians are not required to obtain special certification to prescribe medical marijuana. However, state law requires workers employed in the production and distribution of the product to undergo training.
While university officials reportedly suspended the program, a university-associated website notes enrollment in the program was “suspended temporarily while the business agreements are being finalized by the university,” according to The Baltimore Sun.
The 30-hour program, which officials announced in July, constituted various courses on aspects of the industry, including laws and regulations, plant and product consistency, operating procedures and labeling and inventory control.
It is unclear if a similar program or courses will be offered in the future.
More articles on hospital-physician relationships:
UC San Francisco medical student joins DACA lawsuit against Trump administration
Duke, North Carolina Central University to invest in joint medical research endeavors
Harvard Medical School reaches 94% of $750M fundraising goal
